Vanda Pharmaceuticals Inc. ( VNDA) - Stock Earnings
VNDA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -22.6 million USD | 56.3 million USD |
| 2025Q4 | -141.2 million USD | 57.2 million USD |
| 2026Q1 | -48.6 million USD | 51.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VNDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.5 million USD | 192.6 million USD |
| 2024 | -18.9 million USD | 198.8 million USD |
| 2025 | -220.5 million USD | 216.1 million USD |
| 2026 Est. | — | — |
VNDA
Price: $5.73
52 week price:
Earnings Per Share: -4.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 366.2 million